Deep Track Capital, LP Nektar Therapeutics Transaction History
Deep Track Capital, LP
- $3.05 Billion
- Q2 2024
A detailed history of Deep Track Capital, LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Deep Track Capital, LP holds 17,875,498 shares of NKTR stock, worth $20.9 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
17,875,498
Previous 18,400,000
2.85%
Holding current value
$20.9 Million
Previous $17.1 Million
29.53%
% of portfolio
0.73%
Previous 0.57%
Shares
4 transactions
Others Institutions Holding NKTR
# of Institutions
140Shares Held
135MCall Options Held
32.8KPut Options Held
55.5K-
Black Rock Inc. New York, NY15.2MShares$17.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$15.2 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.46MShares$11.1 Million0.21% of portfolio
-
Eventide Asset Management, LLC Boston, MA7.53MShares$8.81 Million0.16% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.95MShares$8.14 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $219M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...